» Articles » PMID: 36573845

The RISE FOR HEALTH Study: Methods for In-person Assessment and Biospecimen Collection

Abstract

Objectives: To describe the methods for the in-person assessment of the RISE FOR HEALTH (RISE) study, a population-based multicenter prospective cohort study designed to identify factors that promote bladder health and/or prevent lower urinary tract symptoms in adult women, conducted by the Prevention of Lower Urinary Tract Symptoms Research Consortium (PLUS).

Methods And Results: A subset of RISE participants who express interest in the in-person assessment will be screened to ensure eligibility (planned n = 525). Eligible consenting participants are asked to complete 15 physical assessments in addition to height and weight, to assess pelvic floor muscle function, musculoskeletal (MSK) status, and pain, and to provide urogenital microbiome samples. Pelvic floor muscle assessments include presence of prolapse, strength, levator attachment integrity (tear) and myofascial pain. MSK tests evaluate core stability, lumbar spine, pelvic girdle and hip pain and function. Participants are asked to complete the Short Physical Performance Battery to measure balance, lower extremity strength, and functional capacity. All participants are asked to provide a voided urine sample and a vaginal swab for microbiome analyses; a subset of 100 are asked to contribute additional samples for feasibility and validation of a home collection of urinary, vaginal, and fecal biospecimens.

Results: Online and in-person training sessions were used to certify research staff at each clinical center before the start of RISE in-person assessments. Standardized protocols and data collection methods are employed uniformly across sites.

Conclusions: The RISE in-person assessment is an integral portion of the overall population-based RISE study and represents an innovative approach to assessing factors hypothesized to promote bladder health and/or prevent lower urinary tract symptoms. Data collected from this assessment will be used to prioritize future research questions and prevention strategies and interventions. This description of the assessment methods is intended to provide methodologic transparency and inform other researchers who join efforts to understand and improve bladder health.

Citing Articles

Feasibility of Home Collection for Urogenital Microbiome Samples.

Lukacz E, Fok C, Bryant M, Rodriguez-Ponciano D, Meister M, Mueller M Urogynecology (Phila). 2024; 30(11):896-905.

PMID: 38958286 PMC: 11502285. DOI: 10.1097/SPV.0000000000001544.

References
1.
Constantine M, Rockwood T, Rickey L, Bavendam T, Low L, Lowder J . Validation of bladder health scales and function indices for women's research. Am J Obstet Gynecol. 2023; 228(5):566.e1-566.e14. PMC: 10425263. DOI: 10.1016/j.ajog.2022.12.319. View

2.
Pastore E, Katzman W . Recognizing myofascial pelvic pain in the female patient with chronic pelvic pain. J Obstet Gynecol Neonatal Nurs. 2012; 41(5):680-91. PMC: 3492521. DOI: 10.1111/j.1552-6909.2012.01404.x. View

3.
Newman D, Borello-France D, Sung V . Structured behavioral treatment research protocol for women with mixed urinary incontinence and overactive bladder symptoms. Neurourol Urodyn. 2017; 37(1):14-26. PMC: 5907803. DOI: 10.1002/nau.23244. View

4.
Chevalier F, Fernandez-Lao C, Cuesta-Vargas A . Normal reference values of strength in pelvic floor muscle of women: a descriptive and inferential study. BMC Womens Health. 2014; 14:143. PMC: 4251926. DOI: 10.1186/s12905-014-0143-4. View

5.
Bo K, Frawley H, Haylen B, Abramov Y, Almeida F, Berghmans B . An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Neurourol Urodyn. 2016; 36(2):221-244. DOI: 10.1002/nau.23107. View